Biotech Beat: Pfizer (PFE), Nymox Pharmaceutical Corporation (NYMX), Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Cytori Therapeutics (CYTX)

Pfizer Gains On Positive Earnings & Updated Guidance Pfizer (NYSE: PFE) Pfizer released their earnings report for the second quarter today. The report was overwhelmingly positive. While PFE did miss top-line expectations, when it comes to earnings, they beat analyst expectations by $0.04 per share. As a matter of fact, the quarter’s performance was so … Read more

Why Pfizer (PFE) Is A Great Investment Choice These Days

Pfizer (NYSE: PFE) Pfizer has been a very interesting stock to follow this year. While the stock didn’t see much growth throughout the year 2014, that hasn’t necessarily been the case for 2014 as investors have been excited about the big moves the company is making toward growth. For example, Monday and Tuesday, the company … Read more

Investors warm up to the idea of Pfizer snapping up GSK

Some analysts may be slamming a potential Pfizer ($PFE) buyout of GlaxoSmithKline ($GSK), but some investors are hip to the idea. As Bloomberg reports, options traders are paying record prices for bullish GSK options–and this after the British drugmaker lost $11 billion off its market cap in less than three months. Much of that interest … Read more

April Earnings To Watch | ABBV | GILD | PFE | MRK

April is more than half way over. However, the most exciting part of the month for many is soon to come! As we move into earnings season, big names in health care are getting set to release their reports. Below are a few earnings reports that I’ll be watching closely and what I expect to … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more

Stocks That Benefit From The Strong US Dollar

Recently, I’ve had quite a bit to say about the fast paced growth we’ve seen in the US economy. My biggest problem with growth at an unsustainable rate is that it tends to push the value of the dollar up; harming foreign trade in the process. While this is a real concern, I do want … Read more